Antiobesity effects of a sulfur compound thiacremonone mediated via down-regulation of serum triglyceride and glucose levels and lipid accumulation in the liver of db/db mice

Phytotherapy Research

Volumn 26, Issue 9, 2012, Pages 1265-1271

  Ban, Jung Ok ^b   Lee, Dong Hun ^a   Kim, Eun Jin ^a   Kang, Jeong Woo ^a   Kim, Man Sub ^a   Cho, Min Chul ^a,b   Jeong, Heon Sang ^b   Kim, Jong Wan ^c   Yang, Young ^d   Hong, Jin Tae ^b   Yoon, Do Young ^a  

^a Konkuk University   (South Korea)

^b Chungbuk National University   (South Korea)

^c Dankook University   (South Korea)

^d Sookmyung Women's University   (South Korea)

Author keywords

antiobesity effect; garlic extract including bioflavonoids; PPAR ; serum enzyme; thiacremonone

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; FATTY ACID SYNTHASE; GLUCOSE; GLUCOSE TRANSPORTER 4; LIPID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; SULFUR DERIVATIVE; THIACREMONONE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADIPOCYTE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOBESITY EFFECT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DOWN REGULATION; DRUG EFFECT; FATTY LIVER; GLUCOSE BLOOD LEVEL; GLUCOSE TRANSPORT; HISTOPATHOLOGY; LIPID METABOLISM; LIPID STORAGE; MALE; MOUSE; NONHUMAN; OBESITY; PROTEIN EXPRESSION; TRIACYLGLYCEROL BLOOD LEVEL; UPREGULATION; WEIGHT REDUCTION;

3T3-L1 CELLS; ACETYL-COA CARBOXYLASE; ANIMALS; ANTI-OBESITY AGENTS; BLOOD GLUCOSE; BODY WEIGHT; FATTY ACID SYNTHETASE COMPLEX; FATTY LIVER; GARLIC; GLUCOSE; GLUCOSE TRANSPORTER TYPE 4; LIPID METABOLISM; LIVER; MALE; MICE; MICE, INBRED C57BL; MICE, OBESE; OBESITY; PPAR GAMMA; SULFUR COMPOUNDS; THIOPHENES; TRIGLYCERIDES;

ALLIUM SATIVUM; MUS;

EID: 84866077707     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.3729     Document Type: Article

References (27)

1. Abraham NZ, Carty RP, DuFour DR, Pincus MR,. 2007. Clinical enzymology. In Henry's Clinical Diagnosis and Management by Laboratory Methods, McPherson RA, Pincus MR, (eds), 21st edn. WB Saunders: Philadelphia, 245-262.
2. Ambati S, Yang JY, Rayalam S, Park HJ, Della-Fera MA, Baile CA,. 2009. Ajoene exerts potent effects in 3T3-L1 adipocytes by inhibiting adipogenesis and inducing apoptosis. Phytother Res 23: 513-518.
3. Ban JO, Yuk DY, Woo KS, et al., 2007. Inhibition of cell growth and induction of apoptosis via inactivation of NF-kappaB by a sulfur compound isolated from garlic in human colon cancer cells. J Pharmacol Sci 104: 374-383.
4. Bogardus C, Ravussin E, Robbins DC, Wolfe RR, Horton ES, Sims EA,. 1984. Effects of physical training and diet therapy on carbohydrate metabolism in patients with glucose intolerance and non-insulin-dependent diabetes mellitus. Diabetes 33: 311-318.
5. Burtis CA, Ashwood ER, Bruns DE,. 2006. TIETZ Textbook of Clinical Chemistry and Molecular Diagnostics, 4th edn. WB Saunders: Philadelphia.
6. Chawla A, Schwarz EJ, Dimaculangan DD, Lazar MA,. 1994. Peroxisome proliferator-activated receptor (PPAR) gamma: adipose-predominant expression and induction early in adipocyte differentiation. Endocrinology 135: 798-800.
7. Fajas L, Auboeuf D, Raspe E, et al., 1997. The organization, promoter analysis, and expression of the human PPARgamma gene. J Biol Chem 272: 18779-18789.
8. Flegal KM,. 2005. Epidemiologic aspects of overweight and obesity in the United States. Physiol Behav 86: 599-602.
9. Henry RR, Wallace P, Olefsky JM,. 1986. Effects of weight loss on mechanisms of hyperglycemia in obese non-insulin-dependent diabetes mellitus. Diabetes 35: 990-998.
10. Hue JJ, Lee KN, Jeong JH, et al., 2009. Anti-obesity activity of diglyceride containing conjugated linoleic acid in C57BL/6J ob/ob mice. J Vet Sci 10: 189-195.
11. Hwang IG, Woo KS, Kim DJ, et al., 2007. Isolation and identification of an antioxidant substance from heated garlic (Allium sativum L). Food Sci Biotechnol 16: 963-966.
12. Kobayashi K, Forte TM, Taniguchi S, Ishida BY, Oka K, Chan L,. 2000. The db/db mouse, a model for diabetic dyslipidemia: molecular characterization and effects of Western diet feeding. Metabolism 49: 22-31.
13. Kota BP, Huang TH, Roufogalis BD,. 2005. An overview on biological mechanisms of PPARs. Pharmacol Res 51: 85-94.
14. Lane MD, Wolfgang M, Cha SH, Dai Y,. 2008. Regulation of food intake and energy expenditure by hypothalamic malonyl-CoA. Int J Obes (Lond) 32 (Suppl 4): S49-S54.
15. Lee JH, Kim KA, Kwon KB, et al., 2007. Diallyl disulfide accelerates adipogenesis in 3T3-L1 cells. Int J Mol Med 20: 59-64.
16. Lefebvre AM, Chen I, Desreumaux P, et al., 1998. Activation of the peroxisome proliferator-activated receptor gamma promotes the development of colon tumors in C57BL/6J-APCMin/+ mice. Nat Med 4: 1053-1057.
17. McGarry JD,. 2002. Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. Diabetes 51: 7-18.
18. Miner JL, Cederberg CA, Nielsen MK, Chen X, Baile CA,. 2001. Conjugated linoleic acid (CLA), body fat, and apoptosis. Obes Res 9: 129-134.
19. Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM,. 2006. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 295: 1549-1555.
20. Sohn DW, Han CH, Jung YS, Kim SI, Kim SW, Cho YH,. 2009. Anti-inflammatory and antimicrobial effects of garlic and synergistic effect between garlic and ciprofloxacin in a chronic bacterial prostatitis rat model. Int J Antimicrob Agents 34: 215-219.
21. Thomson MJ, Williams MG, Frost SC,. 1997. Development of insulin resistance in 3T3-L1 adipocytes. J Biol Chem 272: 7759-7764.
22. Viollet B, Foretz M, Guigas B, et al., 2006. Activation of AMP-activated protein kinase in the liver: a new strategy for the management of metabolic hepatic disorders. J Physiol 574: 41-53.
23. Viollet B, Guigas B, Leclerc J, et al,. 2009. AMP-activated protein kinase in the regulation of hepatic energy metabolism: from physiology to therapeutic perspectives. Acta Physiol (Oxf) 196: 81-98.
24. Wakil SJ,. 1989. Fatty acid synthase, a proficient multifunctional enzyme. Biochemistry 28: 4523-4530.
25. Wu AHB,. 2001. Diagnostic enzymology and other biochemical markers of organ damage. In Clinical Laboratory Medicine, McClatchey KD, (ed.), 2nd edn. Lippincott Williams & Wilkins: Philadelphia, PA, USA; 281-305.
26. Yang JY, Della-Fera MA, Nelson-Dooley C, Baile CA,. 2006. Molecular mechanisms of apoptosis induced by ajoene in 3T3-L1 adipocytes. Obesity (Silver Spring) 14: 388-397.
27. Zhang YL, Hernandez-Ono A, Siri P, et al., 2006. Aberrant hepatic expression of PPARgamma2 stimulates hepatic lipogenesis in a mouse model of obesity, insulin resistance, dyslipidemia, and hepatic steatosis. J Biol Chem 281: 37603-37615.